Suade Ozlem Badak, Esra Gulturk, Emine Duygu Ersozlu

COVİD-19 SALGINI SIRASINDA ROMATOİD ARTRİT VE ANKİLOZAN SPONDİLİT HASTALARINDA KORKU, FOBİ, ANKSİYETE VE DEPRESYON SEMPTOM DÜZEYLERİ

Amaç: Bu çalışma, romatoid artrit ve remisyondaki ankilozan spondilitte COVID-19 ile ilişkili psikolojik semptom düzeylerini araştırmayı amaçlamaktadır. Yöntemler: 1 Ekim ile 31 Aralık 2020 tarihleri arasında kesitsel bir çalışma yapılmıştır. Kriterleri karşılayan iki yüz kırk sekiz hasta çalışmaya dahil edildi. Koronavirüs kaynaklı korku, fobi, depresyon ve anksiyete belirtileri değerlendirildi. Bu amaçla COVID-19 Korku Ölçeği (FCV-19S), Covid-19 Fobi Ölçeği(C19p-S), Beck Depresyon Ölçeği (BDI), Beck Anksiyete Ölçeği (BAI) kullanıldı. Bulgular: Katılımcıların çoğunda yüksek düzeyde korku, kaygı ve depresif belirtiler vardı. COVID-19 Korku Ölçeği, Covid-19 Fobi Ölçeği, Beck Depresyon Ölçeği ve Beck Anksiyete Ölçeği puanları anlamlı eş zamanlı korelasyonlar gösterdi (p

FEAR, PHOBIA, ANXIETY AND DEPRESSION SYMPTOM LEVELS IN RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS PATIENTS DURING THE COVID-19 OUTBREAK IN TURKEY

Aim: This study aims to investigate the psychological symptom levels associated with COVID-19 in rheumatoid arthritis and ankylosing spondylitis in remission. Methods: A cross-sectional study was conducted between October 1 and December 31, 2020. Two hundred forty-eight patients meeting the criteria were included in the study. Coronavirus-induced fear, phobia, depression, and anxiety symptoms were evaluated. For this purpose, the Fear of COVID-19 Scale (FCV-19S), Covid-19 Phobia Scale (C19P-S), Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI) were used. Results: Most of the participants had high levels of fear, anxiety, and depressive symptoms. C19P-S, FCV-19S, BDI, and BAI scores showed significant simultaneous correlations (p

PDF

___

1. Guan WJ, Ni ZY, Hu Y, et al. China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. Apr 2020;30;382(18):1708-20. https://doi.org/10.1056/NEJMoa2002032.
2. Duculan R, Jannat-Khah D, Mehta B,et al. Variables Associated With Perceived Risk of Contracting SARS-CoV-2 Infection During the COVID-19 Pandemic Among Patients With Systemic Rheumatic Diseases. J Clin Rheumatol. Apr 2021; 1;27(3):120-6. https://doi.org/10.1097/RHU.000000000000168 6.
3. Asmundson, G. J., Taylor, S. Coronaphobia: Fear and the 2019-nCoV outbreak. Journal of Anxiety Disorders. 2020; 70, 102196. https://doi.org/10.1016/j.janxdis. 2020.102196
4. Arpaci, I., Karatas ̧, K., & Baloglu, M. The development and initial tests for the psychometric properties of the COVID-19 Phobia Scale (C19P-S). Personality and DEATH STUDIES 5 Individual Differences.2020; 164, 110108. https://doi.org/10. 1016/j.paid.2020.110108
5. Aletaha D, Neogi T, Silman AJ, et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. Sep 2010;62(9):2569-81. https://doi.org/10.1002/art.27584.
6. Sieper J, Rudwaleit M, Baraliakos X, et al. The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis. Jun 2009;68 Suppl 2:ii1-44. https://doi.org/10.1136/ard.2008.104018.
7. Van der Heijde DM, van 't Hof M, van Riel PL, et al. Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol. Mar 1993;20(3):579-81.
8. Lukas C, Landewé R, Sieper J, et al. Assessment of SpondyloArthritis international Society. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis. Jan 2009;68(1):18-24. https://doi.org/10.1136/ard.2008.094870
9. Ahorsu DK, Lin CY, Imani V, et al. The Fear of COVID-19 Scale: Development and Initial Validation. Int J Ment Health Addict. Mar 2020;27:1-9. https://doi.org/10.1007/s11469-020-00270-8.
10. Haktanir A, Seki T, Dilmaç B. Adaptation and evaluation of Turkish version of the fear of COVID-19 scale. Death Stud. May 2020; 29:1-9. https://doi.org/10.1080/07481187.2020.1773026
11. Steer RA, Beck AT. Beck Anxiety Inventory. In: Zalaquett CP, Wood RJ, editors. Evaluating Stress: A Book of Resource. Lanham: MD: Scarecrow Education.1997; pp. 23–40.
12. Ulusoy M, Hisli N, Erkmen H. Turkish Version of the Beck Anxiety Inventory: Psychometric Properties. Journal of Cognitive Psychotherapy: An International Quarterly.1998;12.
13. Beck AT, Steer RA. Internal consistencies of the original and revised Beck Depression Inventory. J Clin Psychol. Nov 1984;40(6):1365-7. https://doi.org/10.1002/1097-4679(198411)
14. Hisli N. Validity and Reliability study of Beck Depression Inventory Turk J Psychol 1998;6:118–22.
15. Nikopoulou VA, Holeva V, Parlapani E, et al.Mental Health Screening for COVID-19: a Proposed Cut-off Score for the Greek Version of the Fear of COVID-19 Scale (FCV-19S). Int J Ment Health Addict. 2020 Nov 10:1-14. https://doi.org/10.1007/s11469-020-00414-w.
16. Pfefferbaum B, North CS. Mental Health and the Covid-19 Pandemic. N Engl J Med. Aug 6 2020;383(6):510-2. https://doi.org/10.1056/NEJMp2008017.
17. Seyahi E, Poyraz BC, Sut N, et al. The psychological state and changes in the routine of the patients with rheumatic diseases during the coronavirus disease (COVID-19) outbreak in Turkey: a web-based cross-sectional survey. Rheumatol Int. Aug 2020;40(8):1229-38. https://doi.org/10.1007/s00296-020-04626-0.
18. Fiest KM, Hitchon CA, Bernstein CN, et al. CIHR Team “Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease”. Systematic Review and Meta-analysis of Interventions for Depression and Anxiety in Persons With Rheumatoid Arthritis. J Clin Rheumatol. Dec 2017;23(8):425-34. https://doi.org/10.1097/RHU.000000000000048 9.
19. Baysal O, Durmuş B, Ersoy Y, et al. Relationship between psychological status and disease activity and quality of life in ankylosing spondylitis. Rheumatol Int. Jun 2011;31(6):795-800. https://doi.org/10.1007/s00296-010-1381-x. Epub 2010 March 10.
20. Bakioğlu F, Korkmaz O, Ercan H. Fear of COVID-19 and Positivity: Mediating Role of Intolerance of Uncertainty, Depression, Anxiety, and Stress. Int J Ment Health Addict.2020;28:1- 14. https://doi.org/10.1007/s11469-020-00331-y.
21. Bonfá E, Gossec L, Isenberg DA (2021) How COVID-19 is changing rheumatology clinical practice. Nat Rev Rheumatol.2021;17(1):11-5. https://doi.org/10.1038/s41584-020-00527-5
22. Glintborg B, Jensen DV, Engel S, et al. Self- protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry. RMD Open. Jan 2021;7(1):e001505. https://doi.org/10.1136/rmdopen-2020-001505.
23. Sarzi-Puttini P, Marotto D, Caporali R, et al. Montecucco CM, Favalli EG, Franceschini F,et al.Prevalence of COVID infections in a population of rheumatic patients from Lombardy and Marche treated with biological drugs or small molecules: A multicentre retrospective study. J Autoimmun. Jan 2021;116:102545. https://doi.org/10.1016/j.jaut.2020.102545.
24. Smolen JS, Nash P, Durez P, et al. (2013) Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial. Lancet. Mar 2013;381(9870):918-29. https://doi.org/10.1016/S0140-6736(12)61811- X
25. Mikuls TR, Johnson SR, Fraenkel L, et al. American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 3. Arthritis Rheumatol. Feb 2021;73(2):e1-e12. https://doi.org/10.1002/art.41596.
26. Peng S, Lai X, Du Y, et al. Prevalence and Associated Factors for Depressive Symptomatology in Chinese Adults During COVID-19 Epidemic. Front Psychol. Dec 23 2020; 11:616723. https://doi.org/10.3389/fpsyg.2020.616723.
27. Mertens G, Gerritsen L, Duijndam S, et al. Fear of the coronavirus (COVID-19): Predictors in an online study conducted in March. J Anxiety Disord. 2020 Aug 2020;74:102258. https://doi.org/10.1016/j.janxdis.2020.102258.
28. Gupta L, Kharbanda R, Agarwal V, et al. Patient Perspectives on the Effect of the SARS-CoV-2 Pandemic on Patients With Systemic Sclerosis: An International Patient Survey. J Clin Rheumatol. Jan 1, 2021;27(1):31-3. https://doi.org/10.1097/RHU.000000000000168 1.172